Lupin achieves S&P Global ESG score of 91
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
AI-powered cardiometabolic wellness platform for India’s workforce
The antibody was designed and developed at Abzena’s Cambridge, UK,
Subscribe To Our Newsletter & Stay Updated